167 related articles for article (PubMed ID: 7064804)
21. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.
Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV
Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384
[TBL] [Abstract][Full Text] [Related]
22. Peripheral vasodilators in the treatment of cardiac failure.
Forrester JS; da Luz PL
Adv Cardiol; 1976; 17():123-32. PubMed ID: 818884
[No Abstract] [Full Text] [Related]
23. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
[TBL] [Abstract][Full Text] [Related]
24. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
Benotti JR; Grossman W; Braunwald E; Carabello BA
Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of congestive cardiac failure with vasodilators (author's transl)].
Hauf GF; Bubenheimer P; Lönne E; Roskamm H
Dtsch Med Wochenschr; 1981 Nov; 106(48):1607-12. PubMed ID: 7307999
[TBL] [Abstract][Full Text] [Related]
26. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
[TBL] [Abstract][Full Text] [Related]
27. Arteriolar or venous dilatation in left ventricular failure following acute myocardial infarction: a haemodynamic trial of hydralazine and isosorbide dinitrate.
Nelson GI; Ahuja RC; Silke B; Hussain M; Taylor SH
J Cardiovasc Pharmacol; 1983; 5(4):574-9. PubMed ID: 6193353
[TBL] [Abstract][Full Text] [Related]
28. Role of vasodilators in the treatment of congestive heart failure.
Levine TB
Am J Cardiol; 1985 Jan; 55(2):32A-35A. PubMed ID: 2981463
[TBL] [Abstract][Full Text] [Related]
29. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
[TBL] [Abstract][Full Text] [Related]
30. Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
Verma SP; Silke B; Reynolds GW; Kelly JG; Richmond A; Taylor SH
J Cardiovasc Pharmacol; 1992 Aug; 20(2):274-81. PubMed ID: 1381019
[TBL] [Abstract][Full Text] [Related]
31. Isosorbide dinitrate and hydralazine in blacks with heart failure.
Moran AE; Cooper RS
N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15758018
[No Abstract] [Full Text] [Related]
32. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
Cohn JN
Eur Heart J; 1988 Jan; 9 Suppl A():171-3. PubMed ID: 3044793
[TBL] [Abstract][Full Text] [Related]
33. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
Lavitola Pde L; Higa SS
Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
[No Abstract] [Full Text] [Related]
34. Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
Nelson GI; Silke B; Ahuja RC; Walker C; Forsyth DR; Verma SP; Taylor SH
Am Heart J; 1984 Jun; 107(6):1202-9. PubMed ID: 6144266
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of cardiac failure with vasodilators (author's transl)].
Imhof P
Schweiz Rundsch Med Prax; 1978 May; 67(22):219-29. PubMed ID: 418395
[No Abstract] [Full Text] [Related]
36. Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise.
Wilson JR; Ferraro N
Am J Med; 1981 Oct; 71(4):627-33. PubMed ID: 7282752
[TBL] [Abstract][Full Text] [Related]
37. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
Chatterjee K; Parmley WW
J Am Coll Cardiol; 1983 Jan; 1(1):133-53. PubMed ID: 6338075
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
40. Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure.
Massie B; Kramer B; Haughom F
Circulation; 1981 Mar; 63(3):658-64. PubMed ID: 6780233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
